Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    weill | Open Studies | "Stomach Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Gastric Adenocarcinoma;   Gastric Cancer
Interventions: Procedure: FDG-PET;   Procedure: surgery;   Drug: 5-FU;   Drug: capecitabine;   Drug: docetaxel;   Drug: Irinotecan;   Radiation: 3D-CRT;   Radiation: IMRT
2 Not yet recruiting Perioperative Chemo and Pembrolizumab in Gastric Cancer
Conditions: Gastric Cancer;   Adenocarcinoma of the Gastroesophageal Junction
Interventions: Drug: Pembrolizumab;   Drug: Oxaliplatin;   Drug: Capecitabine;   Drug: Epirubicin
3 Recruiting Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")
Condition: Gastric Cancer
Intervention:
4 Recruiting Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis
Intervention:
5 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
6 Recruiting Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
Conditions: Solid Tumors;   Gastric Cancer
Intervention: Drug: FPA144
7 Recruiting A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
Conditions: Gastric Cancer;   Gastroesophageal Junction Cancer
Interventions: Drug: BBI608;   Drug: Paclitaxel;   Other: Placebo
8 Recruiting A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
Conditions: Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma
Interventions: Drug: Ramucirumab;   Drug: Paclitaxel
9 Recruiting GS-5745 With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Condition: Gastric Adenocarcinoma
Interventions: Drug: GS-5745;   Drug: GS-5745 Placebo;   Drug: Leucovorin;   Drug: 5-fluorouracil;   Drug: Oxaliplatin

Study has passed its completion date and status has not been verified in more than two years.